Use of serum C reactive protein and procalcitonin concentrations in addition to symptoms and signs to predict pneumonia in patients presenting to primary care with acute cough: diagnostic study

Abstract

Objectives To quantify the diagnostic accuracy of selected inflammatory markers in addition to symptoms and signs for predicting pneumonia and to derive a diagnostic tool.Design Diagnostic study performed between 2007 and 2010. Participants had their history taken, underwent physical examination and measurement of C reactive protein (CRP) and procalcitonin in venous blood on the day they first consulted, and underwent chest radiography within seven days. Setting Primary care centres in 12 European countries.Participants Adults presenting with acute cough.Main outcome measures Pneumonia as determined by radiologists, who were blind to all other information when they judged chest radiographs. ResultsOf 3106 eligible patients, 286 were excluded because of missing or inadequate chest radiographs, leaving 2820 patients (mean age 50, 40% men) of whom 140 (5%) had pneumonia. Re-assessment of a subset of 1675 chest radiographs showed agreement in 94% (κ 0.45, 95% confidence interval 0.36 to 0.54). Six published "symptoms and signs models" varied in their discrimination (area under receiver operating characteristics curve (ROC) ranged from 0.55 (95% confidence interval 0.50 to 0.61) to 0.71 (0.66 to 0.76)). The optimal combination of clinical prediction items derived from our patients included absence of runny nose and presence of breathlessness, crackles and diminished breath sounds on auscultation, tachycardia, and fever, with an ROC area of 0.70 (0.65 to 0.75). Addition of CRP at the optimal cut off of >30 mg/L increased the ROC area to 0.77 (0.73 to 0.81) and improved the diagnostic classification (net reclassification improvement 28%). In the 1556 patients classified according to symptoms, signs, and CRP >30 mg/L as "low risk" (<2.5%) for pneumonia, the prevalence of pneumonia was 2%. In the 132 patients classified as "high risk" (>20%), the prevalence of pneumonia was 31%. The positive likelihood ratio of low, intermediate, and high risk for pneumonia was 0.4, 1.2, and 8.6 respectively. Measurement of procalcitonin added no relevant additional diagnostic information. A simplified diagnostic score based on symptoms, signs, and CRP >30 mg/L resulted in proportions of pneumonia of 0.7%, 3.8%, and 18.2% in the low, intermediate, and high risk group respectively.Conclusions A clinical rule based on symptoms and signs to predict pneumonia in patients presenting to primary care with acute cough performed best in patients with mild or severe clinical presentation. RESEARCHAddition of CRP concentration at the optimal cut off of >30 mg/L improved diagnostic information, but measurement of procalcitonin concentration did not add clinically relevant information in this group. IntroductionDiagnosis of pneumonia in adults presenting with signs of lower respiratory tract infection in primary care is important because pneumonia requires specific treatment and follow-up, whereas for acute bronchitis expectant management is usually appropriate.1 Nonetheless, accurate diagnosis of pneumonia in primary care is difficult as it...

Medication use in European primary care patients with lower respiratory tract infection: an observational study

“…Symptom severity 37 (14) 42 (16) 41 (14) 39 (16) 20 (10) 37 (14) 35 (15) 41 (11) 31 (13) 36 (16) 41 (15) 40 (15) 37 ( of patients self-medicated with inhaled corticosteroids (10.8%, of whom none had known COPD or asthma) when compared to other countries and the overall study population (2.9%, of whom 30.1% had known COPD or asthma). Self-medication with salicylic acid was more common in Poland.…”

“…The design and study population of the observational and trial part of the study have been described previously. 14,15 Participating …”

Study of Clinical Profile of Community-acquired Pneumonia with Special Reference to C-reactive Protein and Procalcitonin Levels

“…Results of our study match with these findings (Graph 1). In another study conducted by van Vugt et al 18 showed the measurement of PCT added no relevant additional diagnostic information. A simplified diagnostic score based on symptoms signs, and CRP >30 mg/mL resulted in proportions of the pneumonia of 0.7, 3.8, and 18.2% in the low, intermediate, and high-risk group respectively.…”

Clinical Approach to Nonresponsive Pneumonia in Adults Diagnosed by a Primary Care Clinician: A Retrospective Study

“…A number of biomarkers have been considered useful adjuncts for the determination of bacterial pneumonia diagnosis, severity and treatment response in some, but not all, studies. 7,17,26,[39][40][41] Further investigations are certainly needed to confirm the utility of these tests in the patient with CAP who is evaluated as an outpatient. Similarly, the role of rapid diagnostic tests for specific respiratory pathogens in the outpatient setting is still being defined.…”